Matches in SemOpenAlex for { <https://semopenalex.org/work/W1698993839> ?p ?o ?g. }
- W1698993839 endingPage "583" @default.
- W1698993839 startingPage "571" @default.
- W1698993839 abstract "Assorted challenges in physicochemical characterization, sterilization, depyrogenation, and in the assessment of pharmacology, safety, and efficacy profiles accompany pre-clinical development of nanotechnology-formulated drugs. Some of these challenges are not unique to nanotechnology and are common in the development of other pharmaceutical products. However, nanoparticle-formulated drugs are biochemically sophisticated, which causes their translation into the clinic to be particularly complex. An understanding of both the immune compatibility of nanoformulations and their effects on hematological parameters is now recognized as an important step in the (pre)clinical development of nanomedicines. An evaluation of nanoparticle immunotoxicity is usually performed as a part of a traditional toxicological assessment; however, it often requires additional in vitro and in vivo specialized immuno- and hematotoxicity tests. Herein, I review literature examples and share the experience with the NCI Nanotechnology Characterization Laboratory assay cascade used in the early (discovery-level) phase of pre-clinical development to summarize common challenges in the immunotoxicological assessment of nanomaterials, highlight considerations and discuss solutions to overcome problems that commonly slow or halt the translation of nanoparticle-formulated drugs toward clinical trials. Special attention will be paid to the grand-challenge related to detection, quantification and removal of endotoxin from nanoformulations, and practical considerations related to this challenge." @default.
- W1698993839 created "2016-06-24" @default.
- W1698993839 creator A5056750583 @default.
- W1698993839 date "2015-12-01" @default.
- W1698993839 modified "2023-09-24" @default.
- W1698993839 title "Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy" @default.
- W1698993839 cites W1510225188 @default.
- W1698993839 cites W1527003345 @default.
- W1698993839 cites W1651520865 @default.
- W1698993839 cites W1669278039 @default.
- W1698993839 cites W1683117616 @default.
- W1698993839 cites W1832918390 @default.
- W1698993839 cites W1847010100 @default.
- W1698993839 cites W1965738031 @default.
- W1698993839 cites W1968012969 @default.
- W1698993839 cites W1968334024 @default.
- W1698993839 cites W1968817070 @default.
- W1698993839 cites W1969858206 @default.
- W1698993839 cites W1970568912 @default.
- W1698993839 cites W1971944955 @default.
- W1698993839 cites W1972180606 @default.
- W1698993839 cites W1973666722 @default.
- W1698993839 cites W1975970021 @default.
- W1698993839 cites W1981578118 @default.
- W1698993839 cites W1981632082 @default.
- W1698993839 cites W1981776025 @default.
- W1698993839 cites W1981904613 @default.
- W1698993839 cites W1988554418 @default.
- W1698993839 cites W1990735870 @default.
- W1698993839 cites W1991140433 @default.
- W1698993839 cites W1993582638 @default.
- W1698993839 cites W1997252077 @default.
- W1698993839 cites W2001911281 @default.
- W1698993839 cites W2004459336 @default.
- W1698993839 cites W2014530598 @default.
- W1698993839 cites W2016960329 @default.
- W1698993839 cites W2020713872 @default.
- W1698993839 cites W2022022332 @default.
- W1698993839 cites W2022564018 @default.
- W1698993839 cites W2027710934 @default.
- W1698993839 cites W2029609295 @default.
- W1698993839 cites W2031084334 @default.
- W1698993839 cites W2034473036 @default.
- W1698993839 cites W2040380877 @default.
- W1698993839 cites W2041375449 @default.
- W1698993839 cites W2043931994 @default.
- W1698993839 cites W2044493956 @default.
- W1698993839 cites W2045561438 @default.
- W1698993839 cites W2051007534 @default.
- W1698993839 cites W2054992180 @default.
- W1698993839 cites W2059355578 @default.
- W1698993839 cites W2059924784 @default.
- W1698993839 cites W2061157222 @default.
- W1698993839 cites W2061297246 @default.
- W1698993839 cites W2070887446 @default.
- W1698993839 cites W2070976367 @default.
- W1698993839 cites W2071631857 @default.
- W1698993839 cites W2071847993 @default.
- W1698993839 cites W2072176078 @default.
- W1698993839 cites W2072301209 @default.
- W1698993839 cites W2073842800 @default.
- W1698993839 cites W2074947593 @default.
- W1698993839 cites W2075455619 @default.
- W1698993839 cites W2077901294 @default.
- W1698993839 cites W2082556053 @default.
- W1698993839 cites W2083281555 @default.
- W1698993839 cites W2086542079 @default.
- W1698993839 cites W2087017620 @default.
- W1698993839 cites W2088654258 @default.
- W1698993839 cites W2089941377 @default.
- W1698993839 cites W2090441417 @default.
- W1698993839 cites W2090806580 @default.
- W1698993839 cites W2092591554 @default.
- W1698993839 cites W2093283212 @default.
- W1698993839 cites W2093365714 @default.
- W1698993839 cites W2094348762 @default.
- W1698993839 cites W2094862469 @default.
- W1698993839 cites W2099384430 @default.
- W1698993839 cites W2099556482 @default.
- W1698993839 cites W2099751788 @default.
- W1698993839 cites W2101432573 @default.
- W1698993839 cites W2108890560 @default.
- W1698993839 cites W2112909853 @default.
- W1698993839 cites W2112966923 @default.
- W1698993839 cites W2117185636 @default.
- W1698993839 cites W2120402017 @default.
- W1698993839 cites W2122286575 @default.
- W1698993839 cites W2123218036 @default.
- W1698993839 cites W2123366113 @default.
- W1698993839 cites W2124296880 @default.
- W1698993839 cites W2130982526 @default.
- W1698993839 cites W2132333206 @default.
- W1698993839 cites W2138574167 @default.
- W1698993839 cites W2141189015 @default.
- W1698993839 cites W2143214524 @default.
- W1698993839 cites W2143872135 @default.
- W1698993839 cites W2145921425 @default.
- W1698993839 cites W2146481176 @default.